2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Imagem de Miniatura
Arquivos
art_AGGARWAL_2016_American_College_of_RheumatologyEuropean_League_Against_Rheumatism_2017.PDF (175.8 KB)
Citações na Scopus
54
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
AGGARWAL, Rohit
RIDER, Lisa G.
RUPERTO, Nicolino
BAYAT, Nastaran
ERMAN, Brian
FELDMAN, Brian M.
ODDIS, Chester V.
AMATO, Anthony A.
CHINOY, Hector
COOPER, Robert G.
Citação
ARTHRITIS & RHEUMATOLOGY, v.69, n.5, p.898-910, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Methods. Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement among multiple pairwise scenarios in conjoint analysis surveys, where different levels of improvement in 2 core set measures were presented. The PAPRIKA (Potentially All Pairwise Rankings of All Possible Alternatives) method determined the relative weights of core set measures and conjoint analysis definitions. The performance characteristics of the definitions were evaluated on patient profiles using expert consensus (gold standard) and were validated using data from a clinical trial. The nominal group technique was used to reach consensus. Results. Consensus was reached for a conjoint analysis-based continuous model using absolute percent change in core set measures (physician, patient, and extramuscular global activity, muscle strength, Health Assessment Questionnaire, and muscle enzyme levels). A total improvement score (range 0-100), determined by summing scores for each core set measure, was based on improvement in and relative weight of each core set measure. Thresholds for minimal, moderate, and major improvement were >= 20, >= 40, and >= 60 points in the total improvement score. The same criteria were chosen for juvenile DM, with different improvement thresholds. Sensitivity and specificity in DM/PM patient cohorts were 85% and 92%, 90% and 96%, and 92% and 98% for minimal, moderate, and major improvement, respectively. Definitions were validated in the clinical trial analysis for differentiating the physician rating of improvement (P<0.001). Conclusion. The response criteria for adult DM/PM consisted of the conjoint analysis model based on absolute percent change in 6 core set measures, with thresholds for minimal, moderate, and major improvement.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/33013
Referências
  1. Aggarwal R, 2014, ARTHRITIS RHEUMATOL, V66, pS404
  2. Aggarwal R, 2014, ANN RHEUM DIS, V73, P227, DOI 10.1136/annrheumdis-2012-201800
  3. Alexanderson H, 2014, J RHEUMATOL, V41, P581, DOI 10.3899/jrheum.131247
  4. Amato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477
  5. Apaz MT, 2009, ARTHRIT RHEUM-ARTHR, V61, P509, DOI 10.1002/art.24343
  6. BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
  7. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  8. de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697
  9. de Lautour H, 2016, ARTHRIT CARE RES, V68, P667, DOI 10.1002/acr.22741
  10. Delbecq AL, 1975, GROUP TECHNIQUES PRO
  11. Felson D, 2007, ARTHRIT RHEUM-ARTHR, V57, P193, DOI 10.1002/art.22552
  12. Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129
  13. FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602
  14. FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
  15. Hansen P, 2008, J MULTI-CRITERIA DEC, V15, P87, DOI 10.1002/mcda.428
  16. Hengstman GJD, 2006, ANN RHEUM DIS, V65, P1635, DOI 10.1136/ard.2006.052191
  17. Johnson SR, 2014, J CLIN EPIDEMIOL, V67, P706, DOI 10.1016/j.jclinepi.2013.12.009
  18. METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
  19. Miller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262
  20. Moghadam-Kia S, 2015, EXPERT REV CLIN IMMU, V11, P1265, DOI 10.1586/1744666X.2015.1082908
  21. Nair R, 2011, SEMIN ARTHRITIS RHEU, V41, P95, DOI 10.1016/j.semarthrit.2010.12.001
  22. Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254
  23. Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580
  24. Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754
  25. Piram M, 2014, ANN RHEUM DIS, V73, P2168, DOI 10.1136/annrheumdis-2013-203666
  26. Rider LG, 2004, ARTHRITIS RHEUM, V50, P2281, DOI 10.1002/art.20349
  27. Rider LG, 2002, RHEUM DIS CLIN N AM, V28, P935, DOI 10.1016/S0889-857X(02)00027-3
  28. Rider LG, 2016, RHEUMATOLOG IN PRESS
  29. Rider LG, 2017, ARTHRITIS RHEUMATOL, V69, P911, DOI 10.1002/art.40060
  30. Rider LG, 2011, ARTHRITIS RHEUM-US, V63, pS89
  31. Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532
  32. Rider LG, 2011, JAMA-J AM MED ASSOC, V305, P183, DOI 10.1001/jama.2010.1977
  33. Rider Lisa G., 2003, Journal of Rheumatology, V30, P603
  34. Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1
  35. Ruperto N, 2008, ARTHRIT RHEUM-ARTHR, V59, P4, DOI 10.1002/art.23248
  36. Ruperto N, 2016, LANCET, V387, P671, DOI 10.1016/S0140-6736(15)01021-1
  37. Ruperto N, 2011, ARCH DIS CHILD, V96, P596, DOI 10.1136/adc.2010.188946
  38. Ruperto N, 2010, ANN RHEUM DIS, V69, P790, DOI 10.1136/ard.2009.116624
  39. Ruperto Nicolino, 2008, Curr Rheumatol Rep, V10, P142, DOI 10.1007/s11926-008-0025-6
  40. Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3
  41. Taylor WJ, 2013, ARTHRIT CARE RES, V65, P1259, DOI 10.1002/acr.21955
  42. Taylor WJ, 2011, J RHEUMATOL, V38, P1467, DOI 10.3899/jrheum.110274
  43. Tjarnlund A, 2012, ARTHRITIS RHEUM-US, V64, pS323
  44. Utz KS, 2014, THER ADV NEUROL DISO, V7, P263, DOI 10.1177/1756285614555335
  45. van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098
  46. Volochayev Rita, 2012, Open Rheumatol J, V6, P54, DOI 10.2174/1874312901206010054
  47. Ware J Jr, 1993, SF 36 HLTH SURVEY MA

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/17